Industry in brief | Hypera, Reckitt Benckiser, FHCP
29 January 2021
Hypera Pharma has completed the acquisition of a portfolio of OTC and pharmaceutical products from Takeda, Reckitt Benckiser (RB) has invested in the Bombay Shaving Company and a recent survey found the majority of Canadians support a national self-care strategy.
